Confidential treatment has been requested as to certain portions of this document. Each such portion, which has been omitted herein and replaced with a series of three asterisks in brackets [***], has been filed separately with the Securities and...Development, Supply and License Agreement • December 11th, 2009 • AdvanSource Biomaterials Corp • Surgical & medical instruments & apparatus
We refer to the Development, Supply and License Agreement, dated November 11, 1992 (the “Original Agreement’), by and between AdvanSource Biomaterials, Corp. (formerly known as CardioTech International, Inc. and Polymedica Industries, Inc.) (“AdvanSource”) and Bard Access Systems, Inc. (“Bard”), as amended by the Amendment to Development, Supply and License Agreement, dated January 26, 1999 (the “Amendment”) between AdvanSource and Bard, and as modified by the letter agreement between Bard and AdvanSource dated October 30, 2001 (the “First Letter’), the letter agreement between Bard and AdvanSource dated July 1, 2003 (the “Second Letter”) and the letter agreement between Bard and AdvanSource dated April 1, 2004 (the “Third Letter”). The Original Agreement, the Amendment, the First Letter, the Second Letter and the Third Letter are referred to herein collectively as the “Agreement”. Capitalized terms used herein but not defined herein shall have the meanings given such terms in the Agre
